Proteins of purified Epstein-Barr virus
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mature Epstein-Barr virus (EBV) was purified from the culture medium of infected lymphocytes made functionally conditional for Zta activation of lytic replication by an in-frame fusion with a mutant estrogen receptor. Proteins in purified virus preparations were separated by gradient gel electrophoresis and trypsin-digested; peptides were then analyzed by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans. Potential peptides were matched with EBV and human gene ORFs. Mature EBV was mostly composed of homologues of proteins previously found in a herpes virion. However, EBV homologues to herpes simplex virus capsid-associated or tegument components UL7 (BBRF2), UL14 (BGLF3), and EBV BFRF1 were not significantly detected. Instead, probable tegument components included the EBV and γ-herpesvirus-encoded BLRF2, BRRF2, BDLF2 and BKRF4 proteins. Actin was also a major tegument protein, and cofilin, tubulin, heat shock protein 90, and heat shock protein 70 were substantial components. EBV envelope glycoprotein gp350 was highly abundant, followed by glycoprotein gH, intact and furin-cleaved gB, gM, gp42, gL, gp78, gp150, and gN. BILF1 (gp64) and proteins associated with latent EBV infection were not detected in virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For compositional analysis, most studies have focused on viruses with high proteomic complexity, including those in the families Herpesviridae (4–9) and Poxviridae (10–12).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [4]
Citations
Cites
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography
Grünewald, K., Desai, P., Winkler, D. C., Heymann, J. B., Belnap, D. M., Baumeister, W., & Steven, A. C. (2003) · Science · doi:10.1126/science.1090284 · Cited by 586
Evolution of the herpesviruses
Davison, A. J. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00492-8 · Cited by 336
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
The UL6 Gene Product Forms the Portal for Entry of DNA into the Herpes Simplex Virus Capsid
Newcomb, W. W., Juhas, R. M., Thomsen, D. R., Homa, F. L., Burch, A. D., Weller, S. K., & Brown, J. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10923-10932.2001 · Cited by 309
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Proteins associated with purified human cytomegalovirus particles
Baldick, C. J., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6097-6105.1996 · Cited by 176
Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H., & Saifuddin, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4376 · Cited by 169
Grogan, E. A., Jenson, H. B., Countryman, J. K., Heston, L., Gradoville, L., & Miller, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1332 · Cited by 137
Research works printed but not linked: 2
- Hutt-Fletcher, L. M. & Lake, C. M. (2001) Curr. Top. Microbiol. Immunol. 258, 51-64.11443867
- Iwase, H. & Hotta, K. (1993) Methods Mol. Biol. 14, 151-159.8348231
Cited by
Epstein–Barr virus and virus human protein interaction maps
Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702332104 · Cited by 388
Self-citationHerpesvirus assembly: An update
Mettenleiter, T. C., Klupp, B. G., & Granzow, H. (2009) · Virus Research · doi:10.1016/j.virusres.2009.03.018 · Cited by 375
Comprehensive Characterization of Extracellular Herpes Simplex Virus Type 1 Virions
Loret, S., Guay, G., & Lippé, R. (2008) · Journal of Virology · doi:10.1128/jvi.00904-08 · Cited by 365
Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell
Radtke, K., Dohner, K., & Sodeik, B. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00679.x · Cited by 346
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
“One of the most abundant of these in the virus envelope, gp350/220 (22), is responsible for attachment of the virus with high affinity (36) to the complement receptor type 2 (CR2) on B cells (7, 8, 40, 41, 60, 61).”
BackgroundCellular Proteins in Influenza Virus Particles
Shaw, M. L., Stone, K. L., Colangelo, C. M., Gulcicek, E. E., & Palese, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000085 · Cited by 324
“MASCOT scores are used for the SDS-PAGE and LC-MS/MS analysis, while protein prophet HCMV [3] , EBV [6] , VV [10] , HIV-1 [11, 31] , KSHV [8] , MoMLV [13] annexin A1 HCMV [3] , VV [10] , HIV-1 [11] glyceraldehyde- HCMV [3] , HIV-1 [11, 12] , KSHV [8] , hPIV3 [85] , MoMLV [13] annexin A2 HCMV [3] , EBV [6] , HIV-1 [11,…”
BackgroundMethodCepok, S., Zhou, D., Srivastava, R., Nessler, S., Stei, S., Büssow, K., Sommer, N., & Hemmer, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523661 · Cited by 323
Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein
Wu, J.-J., Li, W., Shao, Y., Avey, D., Fu, B., Gillen, J., Hand, T., Ma, S., Liu, X., Miley, W., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.07.015 · Cited by 278
“ORF52 homologues also inhibit cGAS ORF52 is a gammaherpesvirus specific tegument protein (Bortz et al., 2003; Johannsen et al., 2004; O'Connor and Kedes, 2006; Zhu et al., 2005) and shares a high degree of conservation among them (Figure S5A).”
BackgroundInfluentialHerpesvirus assembly: a tale of two membranes
Mettenleiter, T. C., Klupp, B. G., & Granzow, H. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.06.013 · Cited by 265
Chung, C.-S., Chen, C.-H., Ho, M.-Y., Huang, C.-Y., Liao, C.-L., & Chang, W. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2127-2140.2006 · Cited by 253
Structure of a trimeric variant of the Epstein–Barr virus glycoprotein B
Backovic, M., Longnecker, R., & Jardetzky, T. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810530106 · Cited by 232
“The furin-cleavage site of EBV gB (residues 428–432) is cleaved in the Hi-5 insect cells used for expression of recombinant gB (19), similarly to what has been found in vivo (22).”
MethodEpstein-Barr Virus (EBV)-associated Gastric Carcinoma
Iizasa, H., Nanbo, A., Nishikawa, J., Jinushi, M., & Yoshiyama, H. (2012) · Viruses · doi:10.3390/v4123420 · Cited by 225
“However, BMRF2 is not required for cell-to-cell fusion [41,42] and apparently very few BMRF2 molecules exist in the virion [43].”
BackgroundNeuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
Wang, H.-B., Zhang, H., Zhang, J.-P., Li, Y., Zhao, B., Feng, G.-K., Du, Y., Xiong, D., Zhong, Q., Liu, W.-L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7240 · Cited by 215
Self-citationMolecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
Murata, T., Sugimoto, A., Inagaki, T., Yanagi, Y., Watanabe, T., Sato, Y., & Kimura, H. (2021) · Viruses · doi:10.3390/v13122344 · Cited by 193
Proteomics of the Autographa californica Nucleopolyhedrovirus Budded Virions
Wang, R., Deng, F., Hou, D., Zhao, Y., Guo, L., Wang, H., & Hu, Z. (2010) · Journal of Virology · doi:10.1128/jvi.00040-10 · Cited by 182
Klupp, B. G., Granzow, H., Fuchs, W., Keil, G. M., Finke, S., & Mettenleiter, T. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701757104 · Cited by 174
Switching of EBV cycles between latent and lytic states
Murata, T., & Tsurumi, T. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1780 · Cited by 169
“Actually, EBV particles do not contain detectable levels of histones, like other herpesviruses [100].”
BackgroundEpigenetic and epitranscriptomic regulation of viral replication
Tsai, K., & Cullen, B. R. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0382-3 · Cited by 168
Functional roles of the tegument proteins of herpes simplex virus type 1
Kelly, B., Fraefel, C., Cunningham, A. L., & Diefenbach, R. J. (2009) · Virus Research · doi:10.1016/j.virusres.2009.07.007 · Cited by 205
Immune Evasion by Epstein-Barr Virus
Ressing, M. E., van Gent, M., Gram, A. M., Hooykaas, M. J. G., Piersma, S. J., & Wiertz, E. J. H. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_12 · Cited by 182
“Being a component of the EBV tegument, BPLF1 could act both in productively as well as in newly infected cells (Johannsen et al. 2004; van Gent et al. 2014).”
BackgroundHerpesvirus Interactions with the Host Cytoskeleton
Lyman, M. G., & Enquist, L. W. (2009) · Journal of Virology · doi:10.1128/jvi.01718-08 · Cited by 146
van Gent, M., Braem, S., de Jong, A., Delagic, N., Peeters, J. G. C., Boer, I. G. J., Moynagh, P. N., Kremmer, E., Wiertz, E. J. H. J., Ovaa, H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003960 · Cited by 145
“BPLF1’s presence in virions is also supported by detection of this high molecular weight protein (indicated as large tegument protein, LTP) among EBVs structural proteins [53].”
BackgroundEpstein-Barr Virus BGLF4 Kinase Suppresses the Interferon Regulatory Factor 3 Signaling Pathway
Wang, J.-T., Doong, S.-L., Teng, S., Lee, C., Tsai, C.-H. A., & Chen, M. (2008) · Journal of Virology · doi:10.1128/jvi.01099-08 · Cited by 155
“Negative controls (NC) are GAL4AD and GAL4DBD-BGLF4(1-293).”
BackgroundMethodInfluentialEBV Tegument Protein BNRF1 Disrupts DAXX-ATRX to Activate Viral Early Gene Transcription
Tsai, K., Thikmyanova, N., Wojcechowskyj, J. A., Delecluse, H., & Lieberman, P. M. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002376 · Cited by 136
“The EBV major tegument protein BNRF1 is one of the most abundant tegument proteins in the virion [43] and is essential for the establishment of viral latent infection [44], yet its function is largely unknown.”
BackgroundTagawa, T., Albanese, M., Bouvet, M., Moosmann, A., Mautner, J., Heissmeyer, V., Zielinski, C. E., Lutter, D., Hoser, J., Hastreiter, M., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160248 · Cited by 151
Maxwell, K. L., & Frappier, L. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00042-06 · Cited by 120
The Epstein-Barr Virus Regulome in Lymphoblastoid Cells
Jiang, S., Zhou, H., Liang, J., Gerdt, C., Wang, C., Ke, L., Schmidt, S. C. S., Narita, Y., Ma, Y., Wang, S., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.09.001 · Cited by 121
Self-citationMetabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization
McFadden, K., Hafez, A. Y., Kishton, R., Messinger, J. E., Nikitin, P. A., Rathmell, J. C., & Luftig, M. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517141113 · Cited by 118
“B95-8 virus was produced from the B95-8 Z-HT cell line as described (49).”
MethodSelf-citationSalsman, J., Zimmerman, N., Chen, T., Domagala, M., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000100 · Cited by 111
“BKRF4 has not been functionally characterized but its localization in the tegument portion of the virion indicates that it could exert its effects immediately after infection [52].”
BackgroundBirdwell, C. E., Queen, K. J., Kilgore, P. C. S. R., Rollyson, P. A., Trutschl, M., Cvek, U., & Scott, R. S. (2014) · Journal of Virology · doi:10.1128/jvi.00972-14 · Cited by 114
“Inside the virion, the linear EBV genome is essentially devoid of epigenetic modifications (5, 6), but upon entering the host cell, the viral DNA genome circularizes and quickly becomes methylated and histone associated (reviewed in reference 4).”
BackgroundNXP-2 association with SUMO-2 depends on lysines required for transcriptional repression
Rosendorff, A., Sakakibara, S., Lu, S. S., Kieff, E. D., Xuan, Y., Bacco, A. D., Shi, Y. G., Shi, Y., & Gill, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601066103 · Cited by 112
Self-citationA Virus-Like Particle-Based Epstein-Barr Virus Vaccine
Ruiss, R., Jochum, S., Wanner, G., Reisbach, G., Hammerschmidt, W., & Zeidler, R. (2011) · Journal of Virology · doi:10.1128/jvi.05598-11 · Cited by 116
Nowag, H., Guhl, B., Thriene, K., Romao, S., Ziegler, U., Dengjel, J., & Münz, C. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.11.007 · Cited by 104
“EBV's double stranded DNA is encased by an icosahedral nucleocapsid, sheltered by a protein tegument and ultimately surrounded by a viral envelope decorated with viral glycoproteins (Johannsen et al., 2004).”
BackgroundXing, L., & Kieff, E. D. (2007) · Journal of Virology · doi:10.1128/jvi.02244-06 · Cited by 104
“To evaluate the effects of preexistent latency III EBV infection on EBV replication-associated RNA levels, EBV replication was induced in B95-8 cells (34).”
BackgroundSelf-citationEpigenetic lifestyle of Epstein-Barr virus
Buschle, A., & Hammerschmidt, W. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00792-2 · Cited by 115
“In summary, EBV prevents the loading of cellular histones on its newly synthesized DNA [54] and uncouples viral DNA replication from the activity of DNMT1 that maintains the methylation pattern in the newly synthesized strand in cellular DNA [56].”
BackgroundCutting back on pro-protein convertases: the latest approaches to pharmacological inhibition
Fugère, M., & Day, R. W. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.006 · Cited by 101
“A similar PC-mediated processing requirement for viral spread and cytopathicity also occurs with the Epstein-Barr virus gB glycoprotein [5] , the hepatitis B virus e Box 1.”
Herpesviruses hijack host exosomes for viral pathogenesis
Sadeghipour, S., & Mathias, R. A. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.03.005 · Cited by 104
Proteomic Characterization of Pseudorabies Virus Extracellular Virions
Kramer, T., Greco, T. M., Enquist, L. W., & Cristea, I. M. (2011) · Journal of Virology · doi:10.1128/jvi.02253-10 · Cited by 96
“In addition to viral proteins, herpesvirus virions have been previously shown to contain cellular proteins (8, 56, 61, 83, 99, 133, 144).”
BackgroundResultInfluentialSantpere, G., Darré, F., Blanco, S., Alcamí, A., Villoslada, P., Albà, M. M., & Navarro, A. (2014) · Genome Biology and Evolution · doi:10.1093/gbe/evu054 · Cited by 105
Wang, L. W., Wang, Z., Ersing, I., Nobre, L., Guo, R., Jiang, S., Trudeau, S. J., Zhao, B., Weekes, M. P., & Gewurz, B. E. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008030 · Cited by 100
Quinn, L. L., Williams, L. R., White, C., Forrest, C., Zuo, J., & Rowe, M. (2015) · Journal of Virology · doi:10.1128/jvi.02183-15 · Cited by 94
“In addition, as BDLF3 can be detected in the EBV virion (31), this raises the possibility that BDLF3 can act immediately after new infections of B cells to modulate recognition by existing EBV-specific CD4 T cells.”
BackgroundSashihara, J., Burbelo, P. D., Savoldo, B., Pierson, T. C., & Cohen, J. I. (2009) · Virology · doi:10.1016/j.virol.2009.06.013 · Cited by 93
“EBV gp350 is expressed in the virus envelope and on virus-infected cells (Beisel et al., 1985; Johannsen et al., 2004), and antibody to gp350 is known to neutralize virus infectivity (Hoffman et al.”
BackgroundAdhikary, D., Behrends, U., Boerschmann, H., Pfünder, A., Burdach, S. E. G., Moosmann, A., Witter, K., Bornkamm, G. W., & Mautner, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000583 · Cited by 111
“For example, the clones obtained from the T cell line MA passage p17 could be subdivided into four groups: (i) those that recognized BNRF1 or BMRF1, the previously identified targets of the parental T cell line, (ii) those that recognized LCL but neither mini-LCL alone nor mini-LCL pulsed with the recombinant BNRF1 or…”
BackgroundInfluentialThe Epstein–Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells
Xiao, J., Palefsky, J. M., Herrera, R., Berline, J. W., & Tugizov, S. M. (2007) · Virology · doi:10.1016/j.virol.2007.09.012 · Cited by 93
“Proteomic analysis of purified EBV showed that the level of BMRF-2 in the virion envelope is very low (Johannsen et al., 2004).”
MethodSchauflinger, M., Fischer, D., Schreiber, A., Dittmann, M., Walther, P., Mertens, T., & von Einem, J. (2011) · Journal of Virology · doi:10.1128/jvi.01540-10 · Cited by 85
“For example, the homolog of pUL71 in Epstein-Barr virus is BSRF1 (20) and in alphaherpesviruses UL51 (2, 26).”
BackgroundGranato, M., Feederle, R., Farina, A., Gonnella, R., Santarelli, R., Hub, B., Faggioni, A., & Delecluse, H. (2008) · Journal of Virology · doi:10.1128/jvi.02436-07 · Cited by 82
“described absence of this protein in mature virions (9, 15).”
BackgroundThe genome of cyprinid herpesvirus 3 encodes 40 proteins incorporated in mature virions
Michel, B., Leroy, B., Raj, V. S., Lieffrig, F., Mast, J., Wattiez, R., Vanderplasschen, A. F. C., & Costes, B. (2009) · Journal of General Virology · doi:10.1099/vir.0.015198-0 · Cited by 91
Budding of Marburgvirus is associated with filopodia
Kolesnikova, L., Bohil, A. B., Cheney, R. E., & Becker, S. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00842.x · Cited by 84
“For some of these viruses it is suggested that incorporated actin has a continuing functional and structural role within the virion (Ott et al., 1996; Wilk et al., 1999; Johannsen et al., 2004; del Rio et al., 2005).”
BackgroundA gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV
Sun, C., Kang, Y., Fang, X., Liu, Y.-N., Bu, G., Wang, A.-J., Li, Y., Zhu, Q., Zhang, H., Xie, C., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.09.011 · Cited by 84
van Zyl, D. G., Mautner, J., & Delecluse, H. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00104 · Cited by 84
“A single EBV virion comprises more than 30 different capsid, tegument, and envelope proteins (25).”
BackgroundAsai, R., Kato, A., Kato, K., Kanamori, M., Sugimoto, K., Sairenji, T., Nishiyama, Y., & Kawaguchi, Y. (2006) · Journal of Virology · doi:10.1128/jvi.02674-05 · Cited by 78
“As described above, it has been recently reported that BGLF4 protein is a virion tegument or capsid-associated protein (10, 43).”
BackgroundInfluentialPrice, A. M., Dai, J., Bazot, Q., Patel, L., Nikitin, P. A., Djavadian, R., Winter, P. S., Salinas, C. A., Barry, A. P., Wood, K. C., et al. (2017) · eLife · doi:10.7554/elife.22509 · Cited by 76
“B95-8 strain of Epstein-Barr virus was produced from the B95-8 Z-HT cell line as previously described (Johannsen et al., 2004).”
MethodSelf-citationRole of tegument proteins in herpesvirus assembly and egress
Guo, H., Shen, S., Wang, L., & Deng, H. (2010) · Protein & Cell · doi:10.1007/s13238-010-0120-0 · Cited by 84
Spurgers, K. B., Alefantis, T., Peyser, B. D., Ruthel, G. T., Bergeron, A. A., Costantino, J. A., Enterlein, S., Kota, K. P., Boltz, R. C. D., Aman, M. J., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.003418 · Cited by 71
“Additionally, HSPs have been identified in purified virions of HIV-1 [1, 59], HHV-4 [60], HHV-5 [61], HHV-1 [2], and vaccinia virus [62].”
BackgroundEBV gene expression and regulation
Young, L. S., Arrand, J. R., & Murray, P. G. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.028 · Cited by 73
Protein Array Identification of Substrates of the Epstein-Barr Virus Protein Kinase BGLF4
Zhu, J. K., Liao, G., Shan, L., Zhang, J., Chen, M., Hayward, G. S., Hayward, S. D., Desai, P. J., & Zhu, H. (2009) · Journal of Virology · doi:10.1128/jvi.02378-08 · Cited by 70
“Structural proteins identified by the protein chip analysis were the capsid proteins BDLF1 and BORF1 (10), the tegument protein BGLF2, and the envelope glycoproteins gp350, gM, and gN (23, 30, 41).”
BackgroundO'Connor, C. M., & Kedes, D. H. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1574-1583.2006 · Cited by 71
“detected trace amounts of the homologs of these proteins in their analysis of purified virions of EBV, they elected to exclude the proteins from their final list of confirmed EBV-associated proteins (18).”
BackgroundGiovanni Cardone, A., Newcomb, W. W., Cheng, N., Wingfield, P. T., Trus, B. L., Brown, J. C., & Steven, A. C. (2012) · Journal of Virology · doi:10.1128/jvi.00012-12 · Cited by 71
“However, the number of filaments seen per virion is much smaller than the number of UL36 molecules, and it remains possible that T36 capsids could retain a few copies of some other filamentous component, for example, actin (13, 17).”
BackgroundAn Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
Yiu, S. P. T., Zerbe, C. M., Vanderwall, D., Huttlin, E. L., Weekes, M. P., & Gewurz, B. E. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.05.018 · Cited by 76
Epstein–Barr virus latency programs dynamically sensitize B cells to ferroptosis
Burton, E. M., Voyer, J. E., & Gewurz, B. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118300119 · Cited by 73
“B95-8 EBV was prepared as described (61, 62).”
MethodBaquero-Pérez, B., & Whitehouse, A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005274 · Cited by 66
“In support of this notion is the fact that Hsc70 and iHsp70 have also been reported to be incorporated in the virion of the β-herpesvirus HCMV [94] and the γ-herpesvirus EBV [95].”
BackgroundSelf-Assembly of Epstein-Barr Virus Capsids
Henson, B. W., Perkins, E. M., Cothran, J. E., & Desai, P. J. (2009) · Journal of Virology · doi:10.1128/jvi.01733-08 · Cited by 68
“In addition, multiple bands were observed for some polypeptide species, which could be a result of phosphorylation modifications that the herpesvirus small capsid proteins undergo and which has been demonstrated for BFRF3 (19).”
BackgroundBagdonaite, I., Nordén, R., Joshi, H. J., King, S. L., Vakhrushev, S. Y., Olofsson, S., & Wandall, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721746 · Cited by 70
“The EBV O-Glycoproteome—At least nine EBV virion-associated envelope glycoproteins are known (74).”
BackgroundThe Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67
Zhu, F. X., Li, X., Zhou, F., Gao, S., & Yuan, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01275-06 · Cited by 67
“ORF45-deficient MHV-68 also has a defect in primary infection and is not able to express early lytic genes (16).”
BackgroundInfluentialStegen, C., Yakova, Y., Henaff, D., Nadjar, J., Duron, J., & Lippé, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053276 · Cited by 66
“In contrast, the presence of members of the annexin and heat shock protein families as well as cyclophilin A, DDX3X and components of the cytoskeleton have been documented in other Herpesviridae [9,10,11,12,13,14,15,16,17,18,19,20], suggest-”
BackgroundAbbott, R. J. M., Quinn, L. L., Leese, A. M., Scholes, H. M., Pachnio, A., & Rickinson, A. B. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301629 · Cited by 68
“In addition to EBV’s two IE transactivator proteins, the Ag panel included six E proteins with a range of different lytic cycle functions and seven L proteins ranging from virion capsid (BFRF3), tegument (BNRF1), and envelope (gp25, gp42, gp85, gp350) components to an assembly protein (BVRF2) that is not detected in m…”
BackgroundCD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
Smith, N. A., Coleman, C. B., Gewurz, B. E., & Rochford, R. A. (2020) · Journal of Virology · doi:10.1128/jvi.00428-20 · Cited by 72
Tegument Proteins of Kaposi’s Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses
Sathish, N., Wang, X., & Yuan, Y. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00098 · Cited by 69
Verma, D., Bais, S., Gaillard, M., & Swaminathan, S. (2010) · Journal of Virology · doi:10.1128/jvi.01359-10 · Cited by 63
“SRp20 is important for export of intronless histone mRNAs and is thought to act as an export factor by virtue of its ability to bind RNA via its RBD and undergo nucleocytoplasmic shuttling (19, 20).”
BackgroundLiu, X., & Cohen, J. I. (2015) · Journal of Virology · doi:10.1128/jvi.01410-15 · Cited by 65
“BGLF2 is a tegument protein (41) that is expressed with late kinetics and localizes to the nuclei of virus-infected cells undergoing lytic infection (42).”
Backgroundvan Zyl, D. G., Tsai, M., Shumilov, A., Schneidt, V., Poirey, R., Schlehe, B., Fluhr, H., Mautner, J., & Delecluse, H. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007464 · Cited by 62
SoRelle, E. D., Dai, J., Bonglack, E. N., Heckenberg, E., Zhou, J. Y., Giamberardino, S. N., Bailey, J. A., Gregory, S. G., Chan, C. C. W., & Luftig, M. A. (2021) · eLife · doi:10.7554/elife.62586 · Cited by 67
“B95-8 and M81 strains of EBV were generated from the B95-8 Z-HT and M81 cell lines, respectively, as described previously ( Johannsen et al., 2004 ).”
Self-citationGuo, H., Wang, L., Li, P., Zhou, Z. H., & Deng, H. (2009) · Journal of Virology · doi:10.1128/jvi.00497-09 · Cited by 61
“The HSV-1 homologue UL16, EBV homologue BGLF2, RRV homologue ORF33 and HCMV homologue UL94 are also tegument- or virion-associated proteins (26, 35, 41, 43, 57).”
BackgroundMethodReactivation and lytic replication of KSHV
Lukac, D. M., & Yuan, Y. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.027 · Cited by 62
Wang, J.-T., Yang, P., Lee, C., Han, C.-H., Tsai, C.-H. A., & Chen, M. (2005) · Journal of General Virology · doi:10.1099/vir.0.81313-0 · Cited by 60
“Our observation also confirmed the report by Johannsen et al. (2004), showing with tandem mass spectrometry sequencing that BGLF4 was identified as a minor virion-associated protein.”
SoRelle, E. D., Dai, J., Reinoso-Vizcaíno, N. M., Barry, A. P., Chan, C. C. W., & Luftig, M. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111286 · Cited by 60
Self-citationAntibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells
Turk, S. M., Jiang, R., Chesnokova, L. S., & Hutt‐Fletcher, L. M. (2006) · Journal of Virology · doi:10.1128/jvi.00622-06 · Cited by 59
“Antibodies to gp350/220, which is the most abundant glycoprotein in the virion (16), are found at low levels in the saliva of some normal healthy individuals (36).”
BackgroundChiu, Y., Sugden, A. U., & Sugden, B. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.11.009 · Cited by 58
“These insights explain how EBV evades the cellular machinery that deposits histones on newly synthesized DNA (Johannsen et al., 2004).”
Reactivation and lytic replication of EBV
Kenney, S. C. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.026 · Cited by 60
The Epigenetic Life Cycle of Epstein–Barr Virus
Hammerschmidt, W. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_6 · Cited by 57
“Besides viral DNA, the herpesviral capsids do not appear to contain histones or other DNA-associated proteins of cellular or viral origin (Johannsen et al. 2004).”
BackgroundMorgan, S. M., Tanizawa, H., Caruso, L. B., Hulse, M., Kossenkov, A. V., Madžo, J., Keith, K., Tan, Y., Boyle, S., Lieberman, P. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27894-1 · Cited by 56
Mass spectrometry based proteomic studies on viruses and hosts – A review
Zheng, J., Sugrue, R. J., & Tang, K. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.06.045 · Cited by 59
Viral Reprogramming of the Daxx Histone H3.3 Chaperone during Early Epstein-Barr Virus Infection
Tsai, K., Chan, L., Gibeault, R., Conn, K. L., Dheekollu, J., Domsic, J. F., Marmorstein, R., Schang, L. M., & Lieberman, P. M. (2014) · Journal of Virology · doi:10.1128/jvi.01895-14 · Cited by 62
“The EBV-encoded tegument protein BNRF1 is among the most abundant viral proteins brought into host cells by the infecting virions (35).”
BackgroundSilva, J. D. M., Pinheiro-Silva, R., Dhyani, A., & Pontes, G. S. (2020) · BioMed Research International · doi:10.1155/2020/1627824 · Cited by 62
Fugère, M., Appel, J. R., Houghten, R. A., Lindberg, I., & Day, R. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027946 · Cited by 55
“…e.g., human immunodeficiency virus-1 gp160, severe acute respiratory syndromecoronovirus spike, and hepatitis B e antigen (Messageot et al., 2003; Johannsen et al., 2004; Kibler et al., 2004; Bergeron et al., 2005; Chekanov et al., 2006; Richards et al., 2006), and of oncogenic proteins such as…”
BackgroundDresang, L. R., Teuton, J., Feng, H., Jacobs, J., Camp, D., Purvine, S. O., Gritsenko, M. A., Li, Z., Smith, R. D., Sugden, B., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-625 · Cited by 59
“LC-MS/MS based proteomics proved to be more sensitive than tiling arrays in detecting expression from lytic genes, including those reported in mature virions [25].”
BackgroundLi, W., Avey, D. R., Fu, B., Wu, J., Ma, S., Liu, X., & Zhu, F. (2016) · Journal of Virology · doi:10.1128/jvi.02675-15 · Cited by 54
Young, K. A., Herbert, A. P., Barlow, P. N., Holers, V. M., & Hannan, J. P. (2008) · Journal of Virology · doi:10.1128/jvi.01673-08 · Cited by 53
“In B cells, the interaction between EBV and the cell surface is initially mediated by the predominant glycoprotein in the viral envelope, gp350/220, binding to complement receptor type 2 (CR2/CD21) (9, 10, 22, 31, 33, 41).”
BackgroundLing, P. D., Tan, J., Sewatanon, J., & Peng, R. (2008) · Journal of Virology · doi:10.1128/jvi.02752-07 · Cited by 53
“One common theme is that purified virion particles from several gammaherpesviruses contain ORF75/BNRF1 in their tegument (12, 34, 46, 70).”
BackgroundEBV Glycoproteins: Where are we now?
Hutt‐Fletcher, L. M. (2015) · Future Virology · doi:10.2217/fvl.15.80 · Cited by 53
“The most abundant of the virion glycoproteins is gp350 [2], which was identified by several groups in the 1980s as the protein responsible for attachment of virus to B lymphocytes [3].”
BackgroundRoller, R. J., & Fetters, R. (2015) · Journal of Virology · doi:10.1128/jvi.02799-14 · Cited by 50
“pUL7 has also been identified to be a tegument component in HSV, PrV, and HCMV (where the homolog is UL103), but not in EBV (53, 65, 66).”
BackgroundDjavadian, R., Hayes, M., & Johannsen, E. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007114 · Cited by 57
Self-citationThe Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
Sun, C., Chen, X., Kang, Y., & Zeng, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677027 · Cited by 58
“Glycoproteins Similar to other herpesviruses, EBV is an enveloped virus, comprising a membrane decorated with envelope glycoproteins (such as gp350, gp42, gH, gL, and gB), which are crucial for receptor recognition, attachment, and virus–host membrane fusion (8).”
BackgroundSiak, P. Y., Heng, W. S., Teoh, S. S. H., Lwin, Y. Y., & Cheah, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04673-8 · Cited by 58
Sorem, J., & Longnecker, R. (2009) · Journal of General Virology · doi:10.1099/vir.0.007237-0 · Cited by 51
“In EBV virions, most gB present is in the cleaved form with only a fraction of total gB present in the uncleaved form (Johannsen et al., 2004).”
InfluentialStarkey, J. L., Han, J., Chadha, P., Marsh, J. A., & Wills, J. W. (2013) · Journal of Virology · doi:10.1128/jvi.02555-13 · Cited by 48
“In brief, cells were infected at an MOI of 5, and after 18 h, they were lysed in a buffer containing 1% NP-40.”
BackgroundChen, T., Wang, Y., Xu, Z., Zou, X., Wang, P., Ou, X., Li, Y. H., Peng, T., Chen, D., Li, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901196rr · Cited by 50
“BGLF2 is a tegument protein that expressed with late kinetics in EBV-infected cells (33, 64, 65).”
BackgroundComparative analysis of herpesvirus–common proteins
Mocarski, E. S. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.005 · Cited by 50
Genome-wide transcription program and expression of the Rta responsive gene of Epstein–Barr virus
Lu, C., Jeng, Y.-Y., Tsai, C.-H. A., Liu, M., Yeh, S.-W., Hsu, T.-Y., & Chen, M. (2005) · Virology · doi:10.1016/j.virol.2005.09.064 · Cited by 50
“Indeed, the BMRF2 product was not detected in purified EBV particles (Johannsen et al., 2004), suggesting that BMRF2 may play other roles in early viral DNA replication.”
Background
Metadata
- Authors
- Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kieff, Elliott
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-08
- Volume
- 101
- Issue
- 46
- Pages
- 16286-16291
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC528973
- OpenAlex
- W2080385928
- Cited by
- 450
- References
- 35
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 31 · 2023: 31 · 2022: 21 · 2021: 15 · 2020: 23 · 2019: 19 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 19 · 2013: 13 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- National Institutes of Health (5k08ai049943-02)
- National Cancer Institute (CA47006, CA 85180, R35CA047006, P01CA087661, R01CA047006, R01CA085180, CA87661)
- National Institute of Allergy and Infectious Diseases (1K-08 AI49943-03)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- Epstein-Barr virus, tegument proteins, envelope glycoprotein, lytic replication, actin, cofilin, heat shock proteins, latent infection
- MeSH terms
- Chromatography, Liquid, Clone Cells, Herpesvirus 4, Human, Humans, Lymphocytes, Microscopy, Electron, Phosphorylation, Mass Spectrometry, Viral Envelope Proteins, Viral Proteins, Virus Replication, Open Reading Frames, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.